Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

zymogen activator

A technology of zymogen activating peptides and zymogens, applied in growth factors/inducing factors, animal/human proteins, digestive system, etc., can solve the problems of binding affinity limitation, weak therapeutic potential activator peptides, etc.

Inactive Publication Date: 2016-03-23
F HOFFMANN LA ROCHE & CO AG
View PDF14 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although this establishes the ability to allosterically modulate pro-HGF signaling activity by targeting the activation pocket of HGFβ, the therapeutic potential of this approach is limited by the very weak binding affinity (KD ~ 2 mM) of the activator peptide (Landgraf , K.E. et al. (2010) JBiolChem285:40362-72)

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • zymogen activator
  • zymogen activator
  • zymogen activator

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0278] Example 1: Phage display of a specific peptide library of zymogen-like scHGF with an activation pocket yields highly conserved sequence motifs

[0279] To identify peptides that specifically bind the activation pocket of the zymogen-like form of HGFβ (scHGFβ) with high affinity, based on the structural and sequence homology found in the N-terminal residues of the trypsin / chymotrypsin-like serine protease domain, Engineered phage peptide libraries. Interestingly, there is high structural homology between the activation pocket of the trypsin / chymotrypsin-like serine protease domain and that of HGFβ (Kirchhofer, D. et al. (2004) JBiolChem279:39915-24; Kirchhofer, D. et al. (2007) ProcNatlAcadSciUSA104:5306-11), clearly highlighting the functional conservation of the N-terminal insertion mechanism. In addition to structural homology, the pfam (Finn, R.D. et al. (2010) Nucleic Acids Res38:D211-22) consensus sequence profile of N-terminal residues frequently found in trypsin...

Embodiment 2

[0281] Example 2: A synthetic peptide based on a phage-derived consensus motif binds scHGFβ with high affinity and activates the binding of scHGFβ to Met

[0282] Based on the finding that the consensus ZAP contains features consistent with binding and insertion into the activation pocket, several related peptides were synthesized and used in a previously established scHGFβ activation assay to assess their affinity and ability to activate Met binding (Landgraf, K.E. et al. (2010) J BiolChem 285: 40362-72). Since scHGFβ is only weakly able to interact with the MetSema-PSI domain compared to the active HGFβ form, biolayer interferometry was used in the activation assay to measure the direct enhancement of the peptide by scHGFβ on Streptavidin coated with biotinylated Met The ability to synthesize the binding affinity of the sensor surface (Landgraf, K.E. et al. (2010) J Biol Chem 285:40362-72). Thus, titration of the activator peptide should produce a significant increase in th...

Embodiment 3

[0293] Example 3: Synthetic peptides activate pro-HGF and stimulate cell survival

[0294] To test whether these new more potent peptide activators could also activate the full-length form of pro-HGF and stimulate Met signaling, the peptides were screened for activity in a cell survival assay. Uncleaved forms of pro-HGF (scHGF), which are inactive as Met ligands, have been shown to not stimulate cell survival under serum-starved medium conditions; however, activator peptides in combination with scHGF can signal via Met and greatly enhance cell survival, Similar to that of proteolytically activated HGF ligands (Landgraf, K.E. et al. (2010) J Biol Chem 285:40362-72). Peptide titration in the presence of scHGF was performed using Bx-PC3 cells and a robust activation of signaling via Met observed for scHGF was seen, reaching levels equivalent to HGF-induced signaling.

[0295] The IVGG.14 and IVdG.14 peptides exhibited dose-dependent activation of scHGF, EC 50 for ~20μM peptide ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
affinityaaaaaaaaaa
Login to View More

Abstract

Provided herein are zymogen activating molecules, such as zymogen activating peptides, and methods of identifying and using these zymogen activating molecules, such as zymogen activating peptides.

Description

[0001] related application [0002] This application claims Provisional U.S. Application No. 61 / 547,628 filed October 14, 2011, U.S. Application No. 61 / 648,470 filed May 17, 2012, and June 18, 2012 under 35 U.S.C. § 119 The benefit of US Application No. 61 / 661,180, the contents of which are hereby incorporated by reference in their entirety. field of invention [0003] Provided herein are zymogen activating molecules, such as zymogen activating peptides, and methods of identifying and using these zymogen activating molecules, such as zymogen activating peptides. [0004] sequence listing [0005] This application contains a Sequence Listing submitted via EFS-Web and is hereby incorporated by reference in its entirety. The ASCII copy, created on October 10, 2012, is named P4768R1WO_PCTSequenceListing.txt and is 66,227 bytes in size. Background of the invention [0006] Hepatocyte growth factor (HGF), also known as scatterfactor, is a member of the plasminogen-related growt...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K38/18C07K7/06C07K14/475
CPCA61P1/16A61P3/10A61P7/12A61P19/04C07K7/06C07K14/4753
Inventor K.E.兰德格拉芙R.A.拉扎鲁斯
Owner F HOFFMANN LA ROCHE & CO AG
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products